Adam Kinsey is currently Associate Vice President and Regional Head of North America for Global Clinical Trial Operations (GCTO) at Merck Research Laboratories (a division of Merck & Co., Inc.; Rahway, NJ). He has over 27 years of clinical research experience, with the last 9.5 at Merck. He has been a key leader within GCTO, most recently serving as Executive Director, Clinical Sciences & Study Management and Therapeutic Area Section Head for Melanoma, Hepatobiliary Cancers, and Innovative Strategies. Previously, Adam was Clinical Research Director in Oncology where he led country operations activities in the United States for Merck’s oncology pipeline. Adam started his career as a Clinical Research Associate (CRA) and has traversed through various roles in clinical operations of increasing responsibility and scope. He also has experience across a wide array of therapeutic areas and with companies of different sizes and operating models. Adam has a bachelor’s degree in biology from Rice University in Houston. He completed post-baccalaureate course work at Houston Baptist University and coursework toward a Master of Public Health (MPH) degree at the University of Texas School of Public Health in Houston.
